This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Niosomes encapsulated in biohydrogels for resveratrol delivery Supporting Information
-S1-
Supporting Information
Niosomes encapsulated in biohydrogels for tunable delivery of phytoalexin resveratrol
Noelia D. Machado,a,b Mariana A. Fernández,a Marleen Haering,b César Saldíasc and David Díaz Díazb,d*
aInstituto de Investigaciones en Físico-Química de Córdoba (INFIQC-CONICET), Departamento de Química Orgánica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Ciudad
Universitaria, X5000HUA, Córdoba (Argentina). bInstitute of Organic Chemistry, University of Regensburg, Universitätstrasse. 31, 93040 Regensburg (Germany). cDepartamento de Química Física, Facultad de Química, Pontificia Universidad Católica de Chile, Macul, Santiago (Chile). dInstituto de
Productos Naturales y Agrobiología del CSIC, Avda. Astrofísico Francisco Sánchez 3, 38206 La Laguna, Tenerife (Spain).
Niosomes encapsulated in biohydrogels for resveratrol delivery Supporting Information
-S10-
Figure S9. 2 % w/v κ-C:gelatin (1:1 mass ratio) hydrogels. First order kinetic model at pH 1.2.
Niosomes encapsulated in biohydrogels for resveratrol delivery Supporting Information
-S11-
Figure S10. 2 % w/v κ-C:gelatin (1:1 mass ratio) hydrogels. Higuchi model at pH 1.2.
Niosomes encapsulated in biohydrogels for resveratrol delivery Supporting Information
-S12-
Figure S11. 2 % w/v κ-C:gelatin (1:1 mass ratio) hydrogels. Korsmeyer-Peppas model at pH 1.2.
Niosomes encapsulated in biohydrogels for resveratrol delivery Supporting Information
-S13-
Figure S12. 2 % w/v κ-C:gelatin (1:1 mass ratio) hydrogels. Weibull model at pH 1.2.
Niosomes encapsulated in biohydrogels for resveratrol delivery Supporting Information
-S14-
Figure S13. 3 % w/v κ-C:gelatin (1:1 mass ratio) hydrogels . First order kinetic model at pH 1.2.
Niosomes encapsulated in biohydrogels for resveratrol delivery Supporting Information
-S15-
Figure S14. 3 % w/v κ-C:gelatin (1:1 mass ratio) hydrogels . Higuchi model at pH 1.2.
Niosomes encapsulated in biohydrogels for resveratrol delivery Supporting Information
-S16-
Figure S15. 3 % w/v κ-C:gelatin (1:1 mass ratio) hydrogels . Korsmeyer-Peppas model at pH 1.2.
Niosomes encapsulated in biohydrogels for resveratrol delivery Supporting Information
-S17-
Figure S16. 3 % w/v κ-C:gelatin (1:1 mass ratio) hydrogels . Webull model at pH 1.2.
Niosomes encapsulated in biohydrogels for resveratrol delivery Supporting Information
-S18-
Figure S17. 4 % w/v κ-C:gelatin (1:1 mass ratio) hydrogels . First order kinetic model at pH 1.2.
Niosomes encapsulated in biohydrogels for resveratrol delivery Supporting Information
-S19-
Figure S18. 4 % w/v κ-C:gelatin (1:1 mass ratio) hydrogels . Higuchi model at pH 1.2.
Niosomes encapsulated in biohydrogels for resveratrol delivery Supporting Information
-S20-
Figure S19. 4 % w/v κ-C:gelatin (1:1 mass ratio) hydrogels. Korsmeyer-Peppas model at pH 1.2.
Niosomes encapsulated in biohydrogels for resveratrol delivery Supporting Information
-S21-
Figure S20. 4 % w/v κ-C:gelatin (1:1 mass ratio) hydrogels . Weibull model at pH 1.2.
Niosomes encapsulated in biohydrogels for resveratrol delivery Supporting Information
-S22-
Figure S21. 2 % w/v κ-C:gelatin (1:1 mass ratio) hydrogels. First order kinetic model at pH 6.8.
Niosomes encapsulated in biohydrogels for resveratrol delivery Supporting Information
-S23-
Figure S22. 2 % w/v κ-C:gelatin (1:1 mass ratio) hydrogels. Higuchi model at pH 6.8.
Niosomes encapsulated in biohydrogels for resveratrol delivery Supporting Information
-S24-
Figure S23. 2 % w/v κ-C:gelatin (1:1 mass ratio) hydrogels. Korsmeyer-Peppas model at pH 6.8.
Niosomes encapsulated in biohydrogels for resveratrol delivery Supporting Information
-S25-
Figure S24. 2 % w/v κ-C:gelatin (1:1 mass ratio) hydrogels. Weibull model at pH 6.8.
Niosomes encapsulated in biohydrogels for resveratrol delivery Supporting Information
-S26-
Figure S25. 3 % w/v κ-C:gelatin (1:1 mass ratio) hydrogels . First order kinetic model at pH 6.8.
Niosomes encapsulated in biohydrogels for resveratrol delivery Supporting Information
-S27-
Figure S26. 3 % w/v κ-C:gelatin (1:1 mass ratio) hydrogels . Higuchi model at pH 6.8.
Niosomes encapsulated in biohydrogels for resveratrol delivery Supporting Information
-S28-
Figure S27. 3 % w/v κ-C:gelatin (1:1 mass ratio) hydrogels . Korsmeyer-Peppas model at pH 6.8.
Niosomes encapsulated in biohydrogels for resveratrol delivery Supporting Information
-S29-
Figure S28. 3 % w/v κ-C:gelatin (1:1 mass ratio) hydrogels . Weibull model at pH 6.8.
Niosomes encapsulated in biohydrogels for resveratrol delivery Supporting Information
-S30-
Figure S29. 4 % w/v κ-C:gelatin (1:1 mass ratio) hydrogels. First order kinetic model at pH 6.8.
Niosomes encapsulated in biohydrogels for resveratrol delivery Supporting Information
-S31-
Figure S30. 4 % w/v κ-C:gelatin (1:1 mass ratio) hydrogels. Higuchi model at pH 6.8.
Niosomes encapsulated in biohydrogels for resveratrol delivery Supporting Information
-S32-
Figure S31. 4 % w/v κ-C:gelatin (1:1 mass ratio) hydrogels. Korsmeyer-Peppas model at pH 6.8.
Niosomes encapsulated in biohydrogels for resveratrol delivery Supporting Information
-S33-
Figure S32. 4 % w/v κ-C:gelatin (1:1 mass ratio) hydrogels. Weibull model at pH 6.8.
Niosomes encapsulated in biohydrogels for resveratrol delivery Supporting Information
-S34-
6. Photoisomerization experiments
Figure S33. Chromatograms of RSV before (black line) and after UV irradiation (pink and light blue lines for RSV ethanolic control solution and RSV in niosomes, respectively).
Figure S34. Chromatograms of RSV in niosomes encapsulated in hydrogel before and after UV-irradiation (light blue and black lines, respectively).
Table S8. Molar ratio of trans-RSV remaining in the sample after UV irradiation.
Sample trans-RSV remaining Ethanolic control solution 0,26 ± 0,03